Skip to main content

Table 2 Age-adjusted incidence rates per 100,000 person-years, stratified by age and gender

From: Racial differences in six major subtypes of melanoma: descriptive epidemiology

 

NHW

HW

Black

Asian/PI

Total

Melanoma in situ

 All ages

9.19 (9.11–9.28)

1.26 (1.18–1.35)

0.16 (0.13–0.20)

0.34 (0.30–0.38)

6.60 (6.54–6.66)

 <40 years

2.18 (2.12–2.24)

0.21 (0.18–0.24)

0.03 (0.02–0.05)

0.10 (0.08–0.13)

1.31 (1.27–1.34)

 40–64 years

13.97 (13.78–14.16)

1.61 (1.47–1.76)

0.19 (0.14–0.26)

0.48 (0.40–0.57)

9.82 (9.69–9.94)

 65+ years

29.35 (28.93–29.77)

5.14 (4.63–5.70)

0.67 (0.49–0.90)

1.07 (0.87–1.31)

22.72 (22.41–23.04)

 Male

10.71 (10.58–10.85)

1.22 (1.09–1.35)

0.19 (0.14–0.26)

0.35 (0.29–0.42)

7.95 (7.85–8.05)

 Female

8.33 (8.22–8.45)

1.37 (1.26–1.48)

0.15 (0.11–0.19)

0.34 (0.29–0.39)

5.77 (5.70–5.85)

Superficial spreading melanoma

 All ages

9.05 (8.96–9.13)

1.12 (1.05–1.19)

0.15 (0.12–0.18)

0.31 (0.27–0.35)

6.18 (6.13–6.24)

 <40 years

3.35 (3.27–3.42)

0.35 (0.32–0.39)

0.04 (0.02–0.06)

0.11 (0.08–0.14)

1.96 (1.92–2.00)

 40–64 years

14.73 (14.54–14.93)

1.81 (1.66–1.97)

0.20 (0.15–0.27)

0.47 (0.39–0.56)

10.04 (9.91–10.17)

 65+ years

21.09 (20.74–21.45)

2.91 (2.53–3.33)

0.51 (0.35–0.71)

0.81 (0.64–1.02

15.93 (15.67–16.20)

 Male

10.23 (10.10–10.37)

0.98 (0.88–1.09)

0.18 (0.13–0.24)

0.34 (0.28–0.41)

7.20 (7.11–7.29)

 Female

8.27 (8.16–8.39)

1.29 (1.19–1.39)

0.13 (0.09–0.17)

0.29 (0.24–0.34)

5.49 (5.42–5.57)

Nodular melanoma

 All ages

1.80 (1.76–1.84)

0.49 (0.44–0.54)

0.06 (0.04–0.08)

0.14 (0.12–0.17)

1.30 (1.28–1.33)

 <40 years

0.38 (0.35–0.40)

0.08 (0.06–0.10)

0.01 (0.00–0.02)

0.04 (0.02–0.06)

0.23 (0.21–0.24)

 40–64 years

2.31 (2.24–2.39)

0.51 (0.43–0.60)

0.06 (0.03–0.10)

0.14 (0.10–0.19)

1.60 (1.55–1.65)

 65+ years

6.98 (6.78–7.19)

2.26 (1.92–2.65)

0.31 (0.19–0.48)

0.63 (0.47–0.82)

5.46 (5.30–5.61)

 Male

2.51 (2.45–2.58)

0.60 (0.51–0.70)

0.07 (0.04–0.12)

0.19 (0.14–0.24)

1.84 (1.80–1.89)

 Female

1.26 (1.22–1.30)

0.42 (0.36–0.48)

0.05 (0.03–0.08)

0.11 (0.08–0.15)

0.91 (0.88–0.93)

Lentigo maligna melanoma

 All ages

1.87 (1.83–1.90)

0.23 (0.19–0.27)

0.02 (0.01–0.04)

0.06 (0.05–0.08)

1.37 (1.35–1.40)

 <40 years

0.05 (0.04–0.06)

0.01 (0.00–0.01)

0.00

0.01 (0.00–0.02)

0.03 (0.03–0.04)

 40–64 years

1.83 (1.77–1.90)

0.17 (0.13–0.23)

0.01 (0.00–0.04)

0.05 (0.03–0.09)

1.26 (1.22–1.31)

 65+ years

10.11 (9.87–10.36)

1.38 (1.11–1.69)

0.16 (0.08–0.29)

0.33 (0.22–0.47)

7.69 (7.51–7.87)

 Male

2.97 (2.90–3.04)

0.33 (0.26–0.41)

0.04 (0.02–0.08)

0.09 (0.06–0.13)

2.21 (2.16–2.26)

 Female

1.05 (1.02–1.09)

0.17 (0.13–0.21)

0.01 (0.00–0.03)

0.04 (0.02–0.06)

0.77 (0.74–0.80)

Acral lentiginous melanoma, malignant

 All ages

0.21 (0.20–0.22)

0.24 (0.21–0.28)

0.19 (0.16–0.23)

0.17 (0.14–0.20)

0.20 (0.19–0.22)

 <40 years

0.04 (0.03–0.05)

0.02 (0.01–0.02)

0.02 (0.01–0.03)

0.02 (0.01–0.03)

0.03 (0.03–0.04)

 40–64 years

0.25 (0.23–0.28)

0.26 (0.20–0.32)

0.21 (0.16–0.28)

0.17 (0.13–0.23)

0.24 (0.22–0.26)

 65+ years

0.87 (0.80–0.95)

1.24 (0.99–1.54)

0.93 (0.71–1.20)

0.85 (0.67–1.07)

0.90 (0.84–0.96)

 Male

0.22 (0.20–0.24)

0.25 (0.19–0.31)

0.22 (0.16–0.30)

0.20 (0.16–0.26)

0.22 (0.20–0.23)

 Female

0.21 (0.19–0.23)

0.24 (0.20–0.30)

0.18 (0.14–0.22)

0.14 (0.11–0.18)

0.20 (0.18–0.21)

Malignant melanoma, NOS

 All ages

11.73 (11.64–11.83)

2.25 (2.14–2.36)

0.51 (0.45–0.57)

0.66 (0.60–0.72)

8.36 (8.29–8.42)

 <40 years

3.37 (3.30–3.44)

0.48 (0.44–0.53)

0.10 (0.07–0.13)

0.17 (0.14–0.21)

2.02 (1.98–2.07)

 40–64 years

17.35 (17.14–17.56)

2.98 (2.78–3.18)

0.57 (0.48–0.67)

0.83 (0.72–0.94)

12.10 (11.96–12.24)

 65+ years

35.91 (35.45–36.38)

8.46 (7.79–9.18)

2.22 (1.87–2.62)

2.42 (2.11–2.77)

27.92 (27.58–28.28)

 Male

14.63 (14.47–14.79)

2.31 (2.13–2.49)

0.63 (0.53–0.75)

0.69 (0.61–0.79)

10.68 (10.57–10.80)

 Female

9.70 (9.58–9.82)

2.30 (2.16–2.44)

0.43 (0.36–0.50)

0.64 (0.57–0.72)

6.74 (6.66–6.82)

  1. Diagnosed in the period of 1992–2011 in the SEER 13 database. In each cell, estimate (95 % CI). Rates are age-standardized using the U.S. 2000 Census population